Service · Pharma commercial AI transformation
Pharma commercial AI transformation: from fragmented data to a connected data foundation.
I help commercial pharma leaders turn scattered data and stalled pilots into a transformation that holds: a data foundation built on MLOps and DataOps, governance you can trust, a prioritized GenAI use-case roadmap, omnichannel HCP engagement redesigned from push to pull, and the operating model and "translator" talent to keep it running after I leave.
Typical scope
The problem is not ambition. It is fragmented data, missing governance, and pilots that never scale.
Fragmented data blocks AI
Commercial data lives in CRM, ERP, medical, market-access and agency systems that were never meant to talk to each other. When data is scattered, inconsistent and untrusted, even strong GenAI use cases stall before they reach production. As Gartner puts it, without trusted data even the best models fail to deliver.
No governance, no scale
Industry surveys suggest most pharma companies still run on a partial data-governance strategy or none at all — while the AI train has already left the station. Without clear data ownership, quality controls and an MLOps/DataOps backbone, promising pilots stay pilots and the compliance risk quietly grows.
Push-only omnichannel and a missing operating model
HCP engagement designed as relentless push adds to digital fatigue instead of building trust, and the value leaks away. Worse, the scarce skill is rarely a data scientist — it's the "translator" who connects business intent to technology and governance. Without that talent and an operating model around it, transformation depends on heroics.
How a commercial AI transformation actually sticks.
AI-opportunity & data-readiness assessment
We size where AI can move your commercial numbers and pressure-test the data underneath it — sources, quality, ownership, and how far you are from the value McKinsey estimates GenAI can add to pharma commercial functions. You get a clear-eyed picture of the opportunity and the gaps, not a generic maturity score.
Data governance & MLOps/DataOps foundation
We establish a workable governance framework — data ownership, quality, security and compliance against the thousands of regulations life sciences must track — and stand up the MLOps and DataOps practices that turn fragmented, siloed data into connected, trusted data, so models and use cases have a trusted, repeatable foundation to run on.
GenAI use-case roadmap & omnichannel HCP redesign
We prioritize GenAI use cases by value and feasibility, then sequence them into a roadmap leadership can fund. In parallel we redesign omnichannel HCP engagement from push to pull — personalized, on-demand, channel-respectful — so reps and marketers gain a customer-enablement co-pilot rather than another dashboard.
Proof-of-value pilot, operating model & translator talent
We run a focused proof-of-value pilot designed to scale from day one, then build the operating model around it — governance cadence, ways of working, and the "translator" talent that bridges business and technology. The goal is capability you own, not a dependency on me.
What this engagement covers
- Generative AI strategy for pharma commercial
- Pharma data governance & data stewardship
- MLOps/DataOps foundation for life sciences
- Omnichannel HCP engagement redesign (push to pull)
- Prioritized GenAI use-case roadmap & proof-of-value pilot
- Operating model & "translator" talent strategy
How I work: foundation before flash
- Governance and data quality come first — trusted data before clever models.
- Use cases are prioritized by value and feasibility, not scattered across the org.
- Pilots are scoped to scale, with compliance and MLR considered from the start.
- Everything fits your existing platforms and operating model — no rip-and-replace for its own sake.
- I build capability and translator talent in your teams, so the change outlasts the engagement.
Related insights
Supercharge Pharma Operations with AI
How generative AI in pharma operations teams up with MLOps and DataOps to defragment commercial functions, unlock omnichannel HCP engagement, and add value.
Read· 10 minPharma TransformationPharma's Digital Dilemma: Why the Right Talent Matters
Pharma digital transformation talent is the real bottleneck, not technology. Why translators who bridge business and IT decide whether change actually sticks.
Read· 8 minReady to build a connected data foundation?
Commercial AI stalling on fragmented data, thin governance, or pilots that never scale? That's exactly my work — for one global pharma's Swiss affiliate it cut the administrative effort around medical-education events by roughly 50%.